Nigeria Plans 35 New Radiotherapy Machines as Government Targets 30% Reduction in Cancer Burden by 2030

 

Simpson Global Media News Desk

Nigeria is preparing to significantly expand its cancer-treatment capacity, with the Federal Government announcing plans to procure 35 additional linear accelerators over the next three years and establish six cancer centres of excellence as part of a broader strategy to reduce the national cancer burden.

The Minister of State for Health and Social Welfare, Dr Iziaq Adekunle Salako, disclosed the plans on October 7 while declaring open the 2026 International Cancer Week in Abuja, organised by the National Institute for Cancer Research and Treatment, NICRAT.

The government's programme combines investment in radiotherapy with prevention, early detection, diagnostic services, cancer research, data systems and new approaches to treatment.

The Federal Ministry of Health said the measures are being implemented under the Nigeria National Cancer Control Plan 2026–2030, which targets at least a 30 per cent reduction in Nigeria's cancer burden by 2030 through improvements across the cancer-care continuum.

The announcement comes as Nigeria continues to face a substantial cancer burden and persistent challenges involving late diagnosis, limited treatment capacity, financial barriers and shortages of specialised health infrastructure.

A Major Expansion of Radiotherapy Capacity

The proposed 35 linear accelerators represent one of the most significant elements of the Federal Government's current cancer-treatment expansion programme.

Linear accelerators, commonly known as LINACs, are specialised machines used to deliver high-energy radiation to tumours. Radiotherapy is an important component of treatment for many cancers and may be used to destroy cancer cells, shrink tumours or control disease depending on the type and stage of cancer.

The government says the additional machines are intended to expand access to radiotherapy services and strengthen treatment capacity across Nigeria.

The announcement forms part of a wider plan under which six cancer centres of excellence are being developed.

According to the Ministry of Health, three centres have already been constructed and commissioned, while another three are under construction.

The Federal Government's earlier cancer-control announcements identified Katsina, Enugu and Benin among locations where centres had been completed and commissioned, with other centres progressing in different parts of the country.

The strategy is intended to move cancer care closer to patients who might otherwise have to travel long distances for specialised treatment.

Why Radiotherapy Matters

Cancer treatment is not a single procedure.

Depending on the type of cancer, patients may require surgery, chemotherapy, radiotherapy, hormone treatment, targeted medicines, immunotherapy, palliative care or combinations of several approaches.

Radiotherapy is particularly important because it can be used at different stages of treatment.

It can form part of curative treatment for some cancers.

It can also be used after surgery to reduce the risk of recurrence, before surgery in selected cases, or to relieve symptoms when cancer has advanced.

Without adequate radiotherapy capacity, patients may face delays in beginning treatment or may have to travel to another city.

That can add transport and accommodation costs to an already expensive medical journey.

For patients who are weak or seriously ill, repeated long-distance travel can become another burden.

The planned expansion therefore has implications beyond the number of machines purchased.

It is also about geographical access.

Nigeria's Cancer Burden

The scale of the challenge helps explain why the government is putting cancer control at the centre of its health agenda.

The International Agency for Research on Cancer's GLOBOCAN 2022 estimates recorded 127,763 new cancer cases and 79,542 cancer deaths in Nigeria in that year. The five-year prevalence estimate was 269,109 cases.

The figures cover different forms of cancer across the population.

For women, breast cancer was the most commonly diagnosed cancer in the GLOBOCAN estimate, followed by cervical cancer.

For men, prostate cancer was the leading cancer by number of cases.

Across both sexes, breast, prostate and cervical cancers were among the country's leading cancer types.

The Federal Government has described Nigeria as accounting for about 10.5 per cent of Africa's cancer burden.

The Ministry has linked the growing challenge to factors including lifestyle and environmental risks, population ageing, weaknesses in early-detection programmes, inadequate treatment infrastructure and continuing inequalities in access to healthcare.

These factors make cancer control a problem that cannot be solved simply by building more treatment centres.

Prevention and early diagnosis must also improve.

The 30 Per Cent Target

The National Cancer Control Plan 2026–2030 provides the policy framework for the government's approach.

Its goal is to achieve a measurable and sustained reduction in cancer incidence, illness and mortality by 2030.

The plan covers prevention, early detection, treatment, survivorship, research, workforce development, financing, data management and digital health.

The Federal Ministry of Health has set a target of reducing the national cancer burden by at least 30 per cent by 2030.

Achieving that target will require improvements at several points in the healthcare system.

Preventing cancers where possible is one.

Detecting disease earlier is another.

Ensuring that people who receive a diagnosis can actually access appropriate treatment is equally important.

So is helping patients remain in care throughout treatment.

Prevention Comes Before Treatment

Cancer-control programmes increasingly emphasise prevention because some cancers can be reduced through interventions that take place before a person develops disease.

The Nigerian strategy includes vaccination, awareness, risk reduction and screening.

One of the most important preventive interventions is vaccination against human papillomavirus, HPV, which is strongly associated with cervical cancer.

The Federal Ministry of Health said HPV vaccination has reached more than 18 million girls aged nine to 14 across Nigeria.

The vaccination programme is part of the country's broader effort to move toward the World Health Organisation's 2030 cervical cancer elimination target.

The government has also established a National Taskforce on Cervical Cancer Elimination to coordinate efforts in this area.

The significance of HPV vaccination is that it represents prevention before cancer develops.

A girl vaccinated against HPV does not receive protection against every form of cancer, but vaccination can substantially reduce the risk of cervical cancer associated with the targeted HPV types.

That makes immunisation an important part of a long-term cancer strategy.

Eight Preventive Oncology Clinics

The government is also expanding early detection.

The Ministry said eight NICRAT Preventive Oncology Clinics have been established across the six geopolitical zones.

The clinics are intended to strengthen cancer awareness, prevention and early-detection efforts.

Early detection matters because cancers diagnosed at an earlier stage may be easier to treat than cancers discovered after they have advanced.

But awareness alone is not enough.

A person who recognises a possible symptom needs somewhere to go.

The health system must be capable of providing appropriate screening, diagnostic tests, biopsy services, pathology and referral.

That is why the government's strategy links prevention with diagnostic and treatment infrastructure.

The Problem of Late Presentation

Late presentation remains one of the most serious challenges confronting cancer care in Nigeria.

Patients may delay seeking medical attention because they do not recognise symptoms.

Others may initially seek treatment outside the formal healthcare system.

Some may lack the money required for consultations and diagnostic tests.

In other cases, patients may reach a health facility but face delays before receiving a definitive diagnosis.

By the time cancer is confirmed, the disease may have progressed.

The result is a more complicated and expensive treatment journey.

It can also reduce the likelihood of successful treatment.

The National Cancer Control Plan therefore places early detection alongside prevention and treatment rather than treating it as a secondary issue.

Diagnostics Are Central to Cancer Care

The government has also announced expansion of diagnostic services.

One of the measures highlighted by Salako is the introduction of immunohistochemistry services under the Nigeria Cancer Access Partnership Programme.

Immunohistochemistry is a laboratory technique used to identify specific proteins in tissue samples.

It can help pathologists determine the characteristics of a tumour and support diagnosis and treatment decisions.

That may sound highly technical, but its importance is practical.

Cancer is not one disease.

Different tumours behave differently and may respond differently to treatment.

The more accurately a tumour can be characterised, the better clinicians can determine the most appropriate management approach.

Improving pathology capacity can therefore affect the entire treatment pathway.

Cancer Centres of Excellence

The six planned centres of excellence are intended to provide stronger hubs for specialised cancer services.

The Federal Government says three have already been completed and commissioned while three remain under construction.

The idea is to create facilities capable of supporting more comprehensive cancer care.

That includes diagnosis, treatment, specialist services and potentially training and research.

Centralising certain highly specialised services can also make it easier to maintain expensive equipment and assemble multidisciplinary teams.

However, centres of excellence cannot operate effectively on buildings and machines alone.

They require oncologists, radiographers, medical physicists, nurses, pharmacists, laboratory scientists, pathologists, surgeons and other specialists.

They also need reliable electricity, water, maintenance systems, information technology and supply chains.

The Machine Is Only One Part of the System

The planned purchase of 35 linear accelerators is significant, but the machines themselves will not automatically solve Nigeria's radiotherapy challenges.

A LINAC requires trained professionals to operate safely.

It requires maintenance.

It requires appropriate radiation-safety procedures.

It requires stable power and supporting infrastructure.

It requires treatment-planning systems and quality assurance.

And it requires a pipeline of patients who have been properly diagnosed and referred.

The National Cancer Control Plan recognises the importance of workforce development alongside infrastructure expansion. Its objectives include developing and retaining an adequate oncology workforce through training, incentives and task-sharing where appropriate.

That means the success of the 35-machine programme will ultimately depend on whether the broader system grows alongside the equipment.

Building the Workforce

Cancer care is multidisciplinary.

A patient may encounter a primary-care worker, a specialist doctor, a radiologist, a pathologist, a surgeon, a medical oncologist, a radiation oncologist, a radiographer and nurses during different stages of treatment.

Each professional has a role.

A shortage in any part of the chain can create delays.

Training therefore becomes a central part of the expansion programme.

The Federal Government has previously said that workforce development is included in the National Cancer Control Plan.

The government is also seeking partnerships and international collaboration to strengthen technical expertise.

For Nigeria, developing the workforce is particularly important because trained specialists can be lost through migration.

The country must therefore not only train professionals but also create conditions that encourage them to remain in the system.

Retaining Specialists

Brain drain has affected several areas of Nigeria's health sector.

Cancer care is particularly vulnerable because specialist oncology training takes years.

A radiotherapy programme can have expensive equipment but still struggle if there are not enough medical physicists, radiation oncologists, radiographers and other trained professionals.

Workforce planning must therefore operate alongside equipment procurement.

A long-term programme should answer questions about how many professionals will be required, where they will be trained, where they will work and how their skills will be maintained.

This is especially important as new centres come online.

If six centres are developed and dozens of new machines installed, the demand for qualified personnel will increase.

Cancer and Financial Pressure

Cancer treatment can place severe financial pressure on households.

Patients may have to pay for consultations, laboratory tests, imaging, surgery, medicines, transportation and other services.

Even when a particular treatment is available, affordability can determine whether a patient completes the recommended course.

The National Cancer Control Plan therefore includes financing and financial-risk protection as strategic priorities.

The plan also identifies a Cancer Health Fund for vulnerable patients.

The government launched a Social Determinants of Health Assistance Programme under the cancer-control framework earlier in 2026, including financial assistance intended to help patients overcome barriers that could prevent them from accessing or completing treatment.

Such measures recognise that access is not only about whether a hospital has a machine.

A treatment service may exist, but a patient still needs the financial ability to reach and use it.

Health Insurance and Cancer Care

Health financing is therefore connected directly to cancer outcomes.

A cancer diagnosis can require prolonged care.

For households paying out of pocket, repeated expenses can become difficult to sustain.

If patients interrupt treatment because of cost, the medical consequences can be serious.

Expanding financial protection through health insurance and targeted support can help reduce that risk.

The broader health-financing system is also undergoing reform.

A national forum convened in Abuja this week by the Federal Ministry of Health and Social Welfare, the National Health Insurance Authority and partners focused on developing locally led evidence for Nigeria's health-financing decisions. The World Health Organisation's Alliance for Health Policy and Systems Research reported that participants emphasised the need for Nigeria to generate and use its own evidence as external development assistance declines.

That discussion has relevance to cancer because large-scale cancer programmes require sustainable domestic financing.

Data and Cancer Registries

Another pillar of the government's cancer strategy is data.

Cancer control cannot be planned effectively without knowing where cases occur, which cancers are most common, how many patients are receiving treatment and what outcomes they are experiencing.

The National Cancer Control Plan calls for stronger cancer registration and surveillance.

Its digital-health pillar includes a goal of establishing or reactivating functional population-based cancer registries across all six geopolitical zones by 2027, with the objective of covering at least 30 per cent of the population.

The plan also aims to improve national completeness of cancer registration and establish a publicly accessible national cancer-data dashboard.

Better data could help government decide where new facilities are most needed.

It could also help researchers identify changing patterns and evaluate whether interventions are working.

Artificial Intelligence and Digital Health

Technology is becoming another part of the cancer strategy.

The Ministry says Nigeria intends to use digitalisation, artificial intelligence, telemedicine, molecular diagnostics, precision medicine, cancer registries and data analytics to improve cancer care.

The National Cancer Control Plan includes digital and AI objectives designed to help overcome some infrastructure limitations.

Among its stated goals is deployment of AI-assisted pathology and AI-powered cancer-screening decision support in at least 200 facilities by 2027.

The potential is significant.

Digital tools can help clinicians access information and connect patients to specialists.

Telemedicine can support consultations where specialist services are not physically available.

AI-assisted tools may support screening or image interpretation.

But technology must remain an aid to healthcare professionals rather than a substitute for proper clinical judgment.

The Importance of Quality Assurance

As Nigeria expands cancer services, quality assurance becomes increasingly important.

A larger number of facilities does not automatically mean better outcomes.

Cancer treatment must be safe and consistent.

Radiotherapy equipment must be calibrated.

Dosages must be carefully calculated.

Pathology results must be reliable.

Medicines must be properly handled.

Clinical protocols must be followed.

Patients must be monitored.

This is particularly important for radiotherapy because errors can have serious consequences.

The planned expansion must therefore include strong regulatory and quality-assurance systems.

International Partnerships

Nigeria is also relying on international partnerships.

The Federal Ministry of Health has repeatedly highlighted collaboration with international cancer organisations, development partners and other governments as part of the country's cancer-control strategy.

In August, the Ministry said international expertise and partnerships would be critical to implementing the National Cancer Control Plan.

The government has also previously announced cooperation involving China in efforts to expand radiotherapy capacity.

The role of partnerships can extend beyond financing.

They can provide technical expertise, training, research collaboration, equipment support and access to international best practices.

The long-term objective, however, is to build domestic capacity capable of sustaining the programme.

Why Six Centres Are Not Enough

Even if all six centres are completed and equipped, Nigeria's cancer burden will remain too large for a small number of specialised facilities to carry the entire system.

Cancer care needs a network.

Primary healthcare facilities should contribute to prevention and awareness.

Secondary hospitals should support diagnosis and referral.

Specialised centres should provide advanced treatment.

Laboratories should provide pathology.

Pharmacies and supply systems should ensure access to medicines.

Health-insurance structures should support financing.

Community organisations should help with awareness and patient support.

This is why the National Cancer Control Plan describes cancer care as a continuum.

The goal is not simply to build specialised hospitals.

It is to connect different parts of the health system.

Breast Cancer

Breast cancer is particularly important in Nigeria because it is the country's leading cancer by number of cases among women according to GLOBOCAN 2022.

The IARC estimate recorded 32,278 new breast-cancer cases among Nigerian women in 2022.

Early detection can make a substantial difference.

Women need information about symptoms and access to appropriate clinical evaluation.

Suspicious findings require diagnostic investigation.

Confirmed cancers then require staging and appropriate treatment.

The pathway from awareness to treatment must therefore be functional.

An awareness campaign without accessible diagnostic services can leave patients with knowledge but no practical route to care.

Cervical Cancer

Cervical cancer provides another important example because it is one of the cancers where prevention can be particularly powerful.

HPV vaccination can reduce the risk associated with cancer-causing HPV types.

Screening can detect precancerous changes before invasive cancer develops.

Treatment of precancerous lesions can prevent progression.

The Federal Government's HPV vaccination programme and cervical-cancer elimination strategy are therefore major components of the national cancer response.

The target is aligned with the WHO's global effort to eliminate cervical cancer as a public-health problem.

Achieving meaningful progress will require continued vaccination, screening, treatment of precancerous lesions and follow-up.

Prostate Cancer

For Nigerian men, prostate cancer is another major concern.

GLOBOCAN 2022 estimated 18,019 new prostate-cancer cases in Nigeria that year, making it the most commonly diagnosed cancer among Nigerian men in the dataset.

Awareness of symptoms and appropriate medical evaluation are important.

But screening and diagnosis must be handled carefully because prostate health assessment involves clinical judgment and appropriate testing.

The wider lesson is that cancer awareness should encourage people to seek professional advice rather than rely on self-diagnosis.

From Awareness to Action

Cancer campaigns frequently use awareness as their central message.

But awareness only becomes useful when it changes behaviour and improves access to care.

A person who learns about cancer needs to know where to seek help.

A health worker needs to know where to refer a patient.

A laboratory needs to be able to process the specimen.

A specialist needs access to treatment equipment.

A patient needs the financial means to continue treatment.

And the system needs to follow up.

The Federal Government's current approach attempts to connect these steps.

That is one reason the 2026–2030 plan covers the entire cancer-care continuum rather than focusing on treatment alone.

The Role of Research

Cancer treatment is changing rapidly.

New medicines, diagnostic techniques and treatment combinations are emerging around the world.

Nigeria needs research capacity to determine which interventions work best in its own population and healthcare environment.

The National Cancer Control Plan therefore includes research among its strategic areas.

Research can also improve understanding of cancer patterns within Nigeria.

The country has different genetic, environmental, social and economic conditions across regions.

Local research can help answer questions that cannot always be addressed by studies conducted elsewhere.

Cancer Registries and Planning

Reliable cancer registries are especially important for this purpose.

Without good registration, policymakers may underestimate or misunderstand the burden of particular cancers.

A registry can help track incidence, mortality and trends over time.

It can also provide researchers with a foundation for studying outcomes.

The plan's emphasis on improving registry coverage therefore represents an investment in future policy decisions as much as in current cancer care.

The Patient at the Centre

Ultimately, the success of Nigeria's cancer strategy should be measured from the perspective of patients.

For a person receiving a cancer diagnosis, policy documents and procurement announcements are meaningful only if they translate into practical improvements.

That means shorter waits for diagnosis.

More reliable laboratory results.

Accessible specialists.

Functional radiotherapy machines.

Affordable medicines.

Financial assistance where needed.

Better pain and palliative care.

Clear information.

And continuity throughout treatment.

A cancer patient should not have to navigate an unnecessarily fragmented system while dealing with the physical and emotional consequences of the disease.

The Challenge of Maintenance

One of the most important issues after the government's procurement programme will be maintenance.

Medical equipment requires regular servicing.

A machine that is purchased but later becomes non-functional does not increase treatment capacity.

The experience of radiotherapy programmes globally shows that equipment availability depends on maintenance, spare parts, trained engineers, quality control and reliable infrastructure.

Nigeria's plan must therefore account for the full lifecycle of the machines.

That includes procurement, installation, commissioning, training, maintenance and eventual replacement.

The investment should be treated as a long-term health infrastructure programme rather than a one-time equipment purchase.

Electricity and Infrastructure

Radiotherapy centres also depend on stable supporting infrastructure.

Cancer centres require reliable electricity, cooling systems, water, information technology and other services.

Power interruptions can disrupt treatment schedules and affect equipment.

Patients undergoing radiotherapy often receive treatment over multiple sessions.

A disruption may therefore have consequences beyond a single appointment.

The expansion programme must consequently consider infrastructure resilience alongside clinical capacity.

What Happens Next

The immediate next step is implementation.

The government has already announced the procurement plan and identified the six-centre strategy.

Three centres have been commissioned and three are under development.

The next phase will involve equipment procurement, installation, staffing and integration into the wider cancer-care network.

At the same time, the National Cancer Control Plan must move from strategy into measurable programmes at federal and state levels.

The government will also need to track whether prevention and early-detection interventions are producing measurable improvements.

The 30 per cent reduction target provides a benchmark against which progress can ultimately be assessed.

A Test of Implementation

Nigeria has produced health strategies before.

The difficult part has often been implementation.

Cancer control is particularly demanding because it requires sustained investment over many years.

A radiotherapy machine cannot eliminate cancer on its own.

A screening campaign cannot work without follow-up.

A cancer centre cannot function without staff.

A health fund cannot help patients if vulnerable people cannot access it.

And a national plan cannot succeed without cooperation among federal agencies, state governments, hospitals, health professionals, researchers, development partners and communities.

The next three years will therefore test the government's ability to coordinate these different elements.

The Wider Public-Health Goal

The cancer programme also fits into Nigeria's broader effort to strengthen the health system.

Cancer is a noncommunicable disease, but the infrastructure required to manage it—laboratories, imaging, skilled health workers, referral networks, financing and data systems—also benefits patients with other serious diseases.

Improving pathology can help diagnose conditions beyond cancer.

Strengthening digital health can support broader clinical services.

Developing specialist training can improve care across multiple disciplines.

Better financial protection can reduce household vulnerability across the health system.

In that sense, investment in cancer care can have effects beyond oncology.

A Long-Term Measure of Success

The most important measure of the government's programme will ultimately be whether Nigerians survive cancer at higher rates and experience less financial and physical hardship during treatment.

That cannot be determined by the number of machines purchased alone.

It will require data.

It will require patient-outcome monitoring.

It will require reliable cancer registries.

It will require transparency about which facilities are functioning and which services are available.

And it will require continuous evaluation of the National Cancer Control Plan.

The government's digital strategy includes plans for a national cancer-data dashboard, which could make it easier to track progress and identify gaps.

A New Phase for Cancer Control

Nigeria's announcement of 35 additional linear accelerators represents a significant commitment at a time when the country is seeking to strengthen its response to cancer.

The investment is part of a much larger strategy.

Six cancer centres of excellence are being developed.

Eight preventive oncology clinics are operating across the geopolitical zones.

More than 18 million girls aged nine to 14 have been reached through HPV vaccination, according to the Ministry.

Diagnostic capacity is being expanded.

Immunohistochemistry services are being introduced.

Cancer registries and digital systems are being strengthened.

And the National Cancer Control Plan has established a 2030 target for reducing the national burden.

The scale of the programme reflects the scale of the challenge.

GLOBOCAN's 2022 estimate of 127,763 new cancer cases and 79,542 deaths demonstrates why prevention and treatment capacity remain urgent national priorities.

But the programme's success will depend on execution.

The machines must arrive.

The centres must function.

The specialists must be available.

The equipment must be maintained.

Patients must be diagnosed early.

Treatment must be affordable.

And the system must generate enough reliable data to demonstrate whether outcomes are improving.

From Machines to Better Outcomes

The Federal Government's 35-machine commitment is therefore best understood as one component of a broader attempt to change how cancer is managed in Nigeria.

The objective is not merely to increase the number of radiotherapy machines.

It is to create a system in which Nigerians have a better chance of preventing cancer, discovering it earlier, receiving an accurate diagnosis and accessing appropriate treatment without being pushed into financial crisis.

That is a much larger ambition.

The 2026 International Cancer Week theme, “United Against Cancer: Building Resilient, Innovative and Equitable Systems Across the Cancer Care Continuum,” reflects that approach.

Cancer control requires resilience because treatment systems must continue functioning under pressure.

It requires innovation because medical science and technology are changing.

And it requires equity because advanced cancer care is of limited value if only a small proportion of Nigerians can reach it.

Nigeria's 2030 target will therefore be judged not only by what is built in major cities, but by whether improvements reach patients across the country's six geopolitical zones.

The next three years will be critical.

If the planned equipment, centres, workforce, financing, prevention programmes and digital systems are implemented effectively, Nigeria could enter 2030 with a substantially stronger cancer-care network.

If implementation falls behind, the machines and plans may not translate into the outcomes patients need.

For now, the government has set a clear direction: expand treatment capacity, improve early detection, strengthen prevention and use technology and data to make cancer care more accessible.

The challenge is to turn that direction into functioning services.

For Nigerians facing cancer today, that is ultimately the measure that matters most.